Associations among serum lipoprotein(a) levels, apolipoprotein(a) phenotypes, and myocardial infarction in patients with extremely low and high levels of serum lipoprotein(a)

被引:10
|
作者
Saku, K [1 ]
Zhang, B [1 ]
Liu, R [1 ]
Shirai, K [1 ]
Arakawa, K [1 ]
机构
[1] Fukuoka Univ, Sch Med, Dept Internal Med, Jonan Ku, Fukuoka 8140180, Japan
来源
关键词
apolipoprotein(a); lipoprotein(a); myocardial infarction; phenotypes;
D O I
10.1253/jcj.63.659
中图分类号
N09 [自然科学史]; B [哲学、宗教];
学科分类号
01 ; 0101 ; 010108 ; 060207 ; 060305 ; 0712 ;
摘要
A high serum lipoprotein(a) [Lp(a)] level, which is genetically determined by apolipoprotein(a) [apo(a)] size polymorphism, is an independent risk factor for coronary atherosclerosis. However, the associations among Lp(a) levels, apo(a) phenotypes, and myocardial infarction (MI) have not been studied. Patients with MI (cases, n=101, M/F: 86/15, age: 62+/-10y) and control subjects (n=92, M/F: 53/39, age: 58+/-14y) were classified into quintile groups (Groups I to V) according to Lp(a) levels. Apo(a) isoform phenotyping was performed by a sensitive, high-resolution technique using sodium dodecyl sulfate-agarose/gradient polyacrylamide gel electrophoresis (3-6%), which identified 26 different apo(a) phenotypes, including a null type. Groups with higher Lp(a) levels (Groups II, III, and V) had higher percentages of MI patients than that with the lowest Lp(a) levels (Group I) (54%, 56%, or 75% vs. 32%, p<0.05). Groups with different Lp(a) levels had different frequency distributions of apo(a) isoprotein phenotypes: Groups Il, III, IV, and V, which had increasing Lp(a) levels, had increasingly higher percentages of smaller isoforms (A1-A4, A5-A9) and decreasingly lower percentages of large isoforms (A10-A20, A21-A25) compared to Group I. An apparent inverse relationship existed between Lp(a) and the apo(a) phenotype. Subjects with the highest Lp(a) levels (Group V) had significantly (p<0.05) higher serum levels of total cholesterol, apo B, and Lp(a). Patients with Mr and the controls had different distributions of apo(a) phenotypes: ie, more small isoforms and more large size isoforms, respectively (A1-A4/A5-A9/A10-A20/A21-A25: 35.7%/27.7%/20.8%/15.8% and 22.8%/23.9%/29.4%/23.9%, respectively). Lp(a) (parameter estimate+/-standard error: 0.70+/-0.20, Wald chi(2)=12.4, p=0.0004), apo(a) phenotype (-0.43+/-0.15, Wald chi(2)=8.17, p=0.004), High-density lipoprotein-cholesterol, apo A-I, and apo B were significantly associated with MI after adjusting for age, gender, and conventional risk factors, as assessed by a univariate logistic regression analysis. The association between Lp(a) and MI was independent of the apo(a) phenotype, but the association between the apo(a) phenotype and MI was not independent of Lp(a), as assessed by a multivariate logistic regression analysis. This association was not influenced by other MI- or Lp(a)-related lipid variables. These results suggest that apo(a) phenotype contributes tot but does not completely explain, the increased Lp(a) levels in MT. A stepwise logistic recession analysis with and without Lp(a) in the model identified Lp(a) and the apo(a) phenotype as significant predictors for MI, respectively.
引用
收藏
页码:659 / 665
页数:7
相关论文
共 50 条
  • [1] LIPOPROTEIN(A) SERUM LEVELS AND APOLIPOPROTEIN(A) PHENOTYPES IN CHILDREN WITH CHRONIC RENAL-DISEASE
    QUERFELD, U
    LANG, M
    FRIEDRICH, JB
    KOHL, B
    FIEHN, W
    SCHARER, K
    [J]. PEDIATRIC RESEARCH, 1993, 34 (06) : 772 - 776
  • [2] Relationship of apolipoprotein E phenotypes to serum lipid and lipoprotein levels in Japanese schoolchildren
    Okada, T
    Sato, Y
    Iwata, F
    Hara, M
    Kim, H
    Harada, K
    [J]. ACTA PAEDIATRICA, 1998, 87 (04) : 460 - 461
  • [3] Serum lipoprotein(a) and apolipoprotein(a) phenotypes in patients with rheumatoid arthritis
    Asanuma, Y
    Kawai, S
    Aoshima, H
    Kaburaki, J
    Mizushima, Y
    [J]. ARTHRITIS AND RHEUMATISM, 1999, 42 (03): : 443 - 447
  • [4] The association of serum lipoprotein(a) levels with myocardial infarction and ictus cerebri in the elderly
    Postorino, G
    Altavilla, R
    Guerrini, M
    Forconi, S
    [J]. ARCHIVES OF GERONTOLOGY AND GERIATRICS, 1996, : 213 - 216
  • [5] APOLIPOPROTEIN(A) PHENOTYPES AND SERUM LIPOPROTEIN(A) LEVELS IN MAINTENANCE HEMODIALYSIS-PATIENTS WITH WITHOUT DIABETES-MELLITUS
    HIRATA, K
    KIKUCHI, S
    SAKU, K
    JIMI, S
    ZHANG, B
    NAITO, S
    HAMAGUCHI, H
    ARAKAWA, K
    [J]. KIDNEY INTERNATIONAL, 1993, 44 (05) : 1062 - 1070
  • [6] SERUM LIPOPROTEIN LEVELS IN PATIENTS WITH CANCER
    NYDEGGER, UE
    BUTLER, RE
    [J]. CANCER RESEARCH, 1972, 32 (08) : 1756 - &
  • [7] Lipoprotein (a) serum levels in patients with hepatocarcinoma
    Basili, S
    Andreozzi, P
    Vieri, M
    Maurelli, M
    Cara, D
    Cordova, C
    Alessandri, C
    [J]. CLINICA CHIMICA ACTA, 1997, 262 (1-2) : 53 - 60
  • [8] Association of polymorphisms of the apolipoprotein(a) gene with lipoprotein(a) levels and myocardial infarction
    Holmer, SR
    Hengstenberg, C
    Kraft, HG
    Mayer, B
    Pöll, M
    Kürzinger, S
    Fischer, M
    Löwel, H
    Klein, G
    Riegger, GAJ
    Schunkert, H
    [J]. CIRCULATION, 2003, 107 (05) : 696 - 701
  • [9] Serum lipoprotein (a) in patients post myocardial infarction
    Marian Vergara, Peggy
    Torres, Yaquelin
    Anez, Roberto
    Toledo, Alexandra
    Chacin, Maricarmen
    Salazar, Juan
    Amell, Anilsa
    Arraiz, Nailet
    Carrillo, Marisol
    Montiel, Maria
    Prieto, Carem
    Silva Paredes, Carlos
    Cruz, Solbelys
    Cano, Climaco
    Bermudez, Valmore
    [J]. REVISTA LATINOAMERICANA DE HIPERTENSION, 2012, 7 (01): : 13 - 19
  • [10] SERUM LIPOPROTEIN(A) CONCENTRATIONS AND APOLIPOPROTEIN(A) PHENOTYPES IN THE FAMILIES OF NIDDM PATIENTS
    HIRATA, K
    SAKU, K
    JIMI, S
    KIKUCHI, S
    HAMAGUCHI, H
    ARAKAWA, K
    [J]. DIABETOLOGIA, 1995, 38 (12) : 1434 - 1442